Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02218814 · ClinicalTrials.gov registry record · NA

Study to Evaluate ACB Versus FNB Early Postoperative Period Functional Outcomes After TKA

A NA study of Arthroplasty, Replacement, Knee and Nerve Block, sponsored by George Macrinici.

Completed
Registry status
NA
Development phase
106
Enrollment target
1
Study location

NCT02218814: Completed NA study of Arthroplasty, Replacement, Knee and Nerve Block, sponsored by George Macrinici.

NCT02218814 is a NA study of Arthroplasty, Replacement, Knee and Nerve Block that has completed, run by George Macrinici. The registered enrollment target is 106 participants, below the 194-participant average among 12 other Arthroplasty, Replacement, Knee trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02218814, a NA study of Arthroplasty, Replacement, Knee and Nerve Block, has completed, sponsored by George Macrinici.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if patients undergoing a Total Knee Arthroplasty who receive a single shot Adductor Canal nerve block and local infiltration will have improved functional outcomes compared to individuals who receive a femoral nerve block and local infiltration during the first 24 hours post surgery.

Primary Outcome

Maximum Voluntary Isovolumetric Contraction (MVIC) measured in Newtons of the quadriceps muscle normalized to body mass index (N•m/kg). The 6 hours post procedure percent of baseline is considered the primary clinical success criterion variable of this study.

Interventions

  • PROCEDURE Adductor Canal Block, Bupivacaine
  • PROCEDURE Femoral Nerve Block, Bupivacaine

Study Locations (1)

Illinois

  • Presence Saint Joseph Medical Center - Joliet

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2014-08
Est. Completion 2016-01
Phase NA
George Macrinici

1 total trials

What the finished NCT02218814 record still lists

NCT02218814 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 194-participant average among 12 other Arthroplasty, Replacement, Knee trials with a reported enrollment target (45% lower).

The record links to 2 conditions, with Arthroplasty, Replacement, Knee appearing as the primary indexed condition, and to 2 interventions - of which Adductor Canal Block, Bupivacaine is the first listed.

NCT02218814 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT02218814 about?

NCT02218814 is a clinical study titled "Study to Evaluate ACB Versus FNB Early Postoperative Period Functional Outcomes After TKA". The purpose of this study is to determine if patients undergoing a Total Knee Arthroplasty who receive a single shot Adductor Canal nerve block and local infiltration will have improved functional outcomes compared to individuals who receive a femoral nerve block and local infiltration during the fi...

What is the current status of trial NCT02218814?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2014-08. Estimated completion is 2016-01.

What conditions does trial NCT02218814 study?

This clinical trial studies the following conditions: Arthroplasty, Replacement, Knee, Nerve Block.

What interventions are being tested in trial NCT02218814?

The interventions under investigation include: Adductor Canal Block, Bupivacaine (PROCEDURE), Femoral Nerve Block, Bupivacaine (PROCEDURE).

Who is sponsoring clinical trial NCT02218814?

This trial is sponsored by George Macrinici, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02218814 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arthroplasty, Replacement, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02218814's enrollment target sits among peer trials

106 8th of 12 higher than 5 of 12 other Arthroplasty, Replacement, Knee trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Arthroplasty, Replacement, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03181048 · 106 participants · NA

    Clinical Trial of Concomitant Hip Arthroscopy During PAO

  • NCT04682158 · 106 participants · Phase 2

    Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

  • NCT04724018 · 106 participants · Phase 1

    Sacituzumab Govitecan Plus EV in Metastatic UC

  • NCT04798274 · 106 participants · NA

    Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02218814, the US trial registry maintained by the National Library of Medicine. NCT02218814 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.